Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06700109 · ClinicalTrials.gov registry record · NA
Injectable Cold Energy Therapy FOR THE Management OF Chronic Pain Associated With Osteoarthritis OF THE Knee
A NA study of Osteoarthritis (OA) of the Knee, sponsored by Brixton Biosciences.
- Active
- Registry status
- NA
- Development phase
- 263
- Enrollment target
- 15
- Study locations
NCT06700109 is a NA study of Osteoarthritis (OA) of the Knee that is active but no longer recruiting, run by Brixton Biosciences. The registered enrollment target is 263 participants, below the 1,381-participant average among 8 other Osteoarthritis (OA) of the Knee trials with a reported enrollment target (81% lower). The trial reports 15 study locations across 13 states.
The verdict
NCT06700109, a NA study of Osteoarthritis (OA) of the Knee, is active but no longer recruiting, sponsored by Brixton Biosciences.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 263 participants
- Enrollment target
- 15
- Study locations
Study Summary
The goal of this clinical trial is to evaluate the effectiveness of Neural Ice for pain management associated with knee osteoarthritis in adults aged 22-80 years. Participants will attend study visits and complete subject diaries. Participants will be followed for 6 months after study procedure.
Conditions Studied
Interventions
- DEVICE Neural Ice
- DRUG Triamcinolone acetate
Study Locations (15)
Oklahoma
- Clinical Investigations, LLC - Edmond
- NextStage Clinical Research The Orthopedic Center - Tulsa
Texas
- NextStage Clinical Research All-American Orthopedic & Sports Medicine Institute - Houston
- UT San Antonio - San Antonio
California
- Marin Health - Larkspur
District of Columbia
- Centers for Advanced Orthopedics - Washington D.C.
Florida
- The Orthopaedic Institute - Gainesville
Georgia
- Emory University - Johns Creek
Illinois
- Insight Hospital and Medical Center Chicago - Chicago
Kansas
- NextStage Clinical Research Advanced Orthopaedic Associates - Wichita
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 263 participants |
| Start Date | 2024-11-19 |
| Est. Completion | 2027-02-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06700109
The ClinicalTrials.gov registry entry for NCT06700109 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 263 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,381-participant average among 8 other Osteoarthritis (OA) of the Knee trials with a reported enrollment target (81% lower). The listed sponsor is Brixton Biosciences, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Osteoarthritis (OA) of the Knee appearing as the primary indexed condition, and to 2 interventions - of which Neural Ice is the first listed.
NCT06700109 reports 15 study locations spanning 13 distinct geographic areas - top geographies include Oklahoma, Texas, California.
Frequently Asked Questions
What is clinical trial NCT06700109 about?
NCT06700109 is a clinical study titled "Injectable Cold Energy Therapy FOR THE Management OF Chronic Pain Associated With Osteoarthritis OF THE Knee". The goal of this clinical trial is to evaluate the effectiveness of Neural Ice for pain management associated with knee osteoarthritis in adults aged 22-80 years. Participants will attend study visits and complete subject diaries. Participants will be followed for 6 months after study procedure.
What is the current status of trial NCT06700109?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 263 participants. The study started on 2024-11-19. Estimated completion is 2027-02-01.
What conditions does trial NCT06700109 study?
This clinical trial studies the following conditions: Osteoarthritis (OA) of the Knee.
What interventions are being tested in trial NCT06700109?
The interventions under investigation include: Neural Ice (DEVICE), Triamcinolone acetate (DRUG).
Who is sponsoring clinical trial NCT06700109?
This trial is sponsored by Brixton Biosciences, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06700109 being conducted?
This trial has 15 study locations across California, District of Columbia, Florida, Georgia, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Osteoarthritis (OA) of the Knee
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Platelet Rich Plasma for Musculoskeletal Conditions
RECRUITING · NA
-
Native Alignment in the Setting of an Arthritic Knee in Total Knee Arthroplasty
RECRUITING · NA
-
Impact of Bone-Marrow Aspirate Injections in Knee Arthroscopy
RECRUITING · NA
-
Photographic Evidence on Total Knee Arthroplasty Outcomes
COMPLETED · NA
-
A Study to Assess Safety and Tolerability of PCRX-201 in Subjects With Painful Osteoarthritis of the Knee
RECRUITING · Phase 2
-
Systemic Oral Glucocorticoids for the Treatment of Acute Osteoarthritis Pain in the Emergency Department
RECRUITING · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.